Clinical evidence for antileukotriene therapy in the management of allergic rhinitis
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (4) , 23-29
- https://doi.org/10.1016/s1081-1206(10)62025-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trialJournal of Allergy and Clinical Immunology, 2000
- 1131 Combination of montelukast and loratadine in seasonal allergic rhinitis: An analysis of three spring studiesJournal of Allergy and Clinical Immunology, 2000
- Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialEuropean Respiratory Journal, 1999
- Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 1999
- Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and ImmunologyAnnals of Allergy, Asthma & Immunology, 1998
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Measuring health-related quality of life in rhinitis☆☆☆★Journal of Allergy and Clinical Immunology, 1997
- Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patientsEuropean Archives of Oto-Rhino-Laryngology, 1995
- Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase InhibitorNew England Journal of Medicine, 1990
- Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humansClinical and Experimental Allergy, 1986